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OBJECTIVES The high sensitivity of electron beam tomography (EBT) in the detection of coronary artery
calcium (CAC) and obstructive coronary artery disease prompted us to investigate the
association between CAC detection and future cardiac events in patients with acute chest pain
syndromes requiring hospitalization.
BACKGROUND Three studies have documented that EBT is a rapid and efficient screening tool for patients
admitted to the emergency department (ED) with chest pain, but there is a paucity of
long-term follow-up data on these chest pain patients.
METHODS We conducted a prospective observational study of 192 patients admitted to the ED of a large
tertiary care hospital for chest pain syndromes. Upon admission, patients underwent EBT
scanning in addition to the usual care for chest pain syndromes. During the 17-month
enrollment period, 221 patients were scanned (54% men with a mean age of 53 6 9 years).
Average follow-up was 50 6 10 months using chart review.
RESULTS Fifty-eight patients had coronary events confirmed by a blinded medical record review. The
presence of CAC (a total calcium score .0) and increasing score quartiles were strongly
related to the occurrence of hard cardiac events including myocardial infarction and death
(p , 0.001) and all cardiovascular events (p , 0.001). Stratification by age- and gender-
matching further increased the prognostic ability of EBT (for scores above vs. below the age-
and gender-matched CAC scores; odds ratio: 13.1, 95% confidence intervals: 5.62, 35.9).
CONCLUSIONS These data support previous reports demonstrating that the presence of CAC in a
symptomatic cohort is a strong predictor of future cardiac events. This study supports the use
of EBT in a symptomatic cohort with prompt discharge of those patients with negative scans.
Furthermore, the absence of CAC is associated with a very low risk of future cardiac risk
events in this population over the subsequent seven years (annual event rate ,1%). (J Am
Coll Cardiol 2001;38:105–10) © 2001 by the American College of Cardiology
Electron beam tomography (EBT) is a sensitive, accurate,
quantitative and reproducible method to detect coronary
artery calcium (CAC), a marker of plaque burden (1–4).
Studies have demonstrated that the absence of CAC is
associated with a very low event rate in symptomatic (5,6)
and asymptomatic cohorts (7–10).
Every year over 1.5 million patients are admitted to the
hospital after presenting to the emergency department (ED)
with chest pain (11). Only a small percentage of these
admitted persons have acute coronary syndromes, and the
vast majority of patients are discharged with noncardiac
diagnoses. Patients who present to the ED with equivocal or
indeterminate findings on initial evaluation are commonly
admitted to the hospital. Three studies have documented
that EBT is a rapid and efficient screening tool for patients
admitted to the ED with chest pain and nonspecific
electrocardiograms (ECG) (12–14). The reluctance to ac-
cept this modality in the ED setting has been due to a
paucity of long-term follow-up data on these chest pain
patients (15). Thus, we sought to follow patients originally
scanned in an ED upon presentation with chest pain and
follow this group for seven years for subsequent cardiac
events.
METHODS
Patient population. Harbor-UCLA Medical Center is an
urban county teaching hospital. The annual ED census is
90,000 patients. The study was conducted between April 1,
1992 and August 30, 1993. Patients were eligible for the
study if they were 30 years of age or older, presented to the
ED with chest discomfort lasting 20 min or more within the
past 12 h, had a nondiagnostic ECG and were believed to
require admission to exclude myocardial infarction (MI).
Unstable patients exhibiting systolic blood pressure of
,90 mm Hg or .180 mm Hg, heart rate ,50 beats/min or
.120 beats/min, pulmonary rales of at least two-thirds of
the way up to the posterior thorax, chest X-ray diagnostic of
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significant congestive heart failure, ventricular tachycardia
.10 beats/min, ventricular fibrillation, rapid atrial fibrilla-
tion (.120 beats/min) unresponsive to treatment, complete
heart block, symptomatic Mobitz type I second-degree
atrioventricular block and Mobitz type II block unrespon-
sive to treatment were excluded from the study. Patients
with ECG evidence of prior MI, coronary artery bypass
graft surgery, percutaneous transluminal coronary angio-
plasty or chest pain unresponsive to treatment were ex-
cluded. Patients with known or suspected pregnancy were
excluded. Patients with ST segment elevation .1 mm in
two consecutive leads or evidence of significant ischemic T
wave inversion of $5 mm were also excluded from the
study.
Stable patients meeting entrance criteria underwent in-
formed consent and were scanned. The EBT scanner was
available from 7 AM to 11 PM, five days a week. This study
was approved by the Institutional Review Board at Harbor-
UCLA Research and Education Institute.
EBT protocol. EBT CORONARY SCAN PROTOCOL. The
EBT studies were performed with the Imatron C-150XL
Ultrafast computed tomographic scanner (Imatron, San
Francisco, California) in the high-resolution volume mode
using a 100-ms exposure time. Electrocardiographic trig-
gering was employed at 80% of the R-R interval, so that
each image was obtained at the same point in diastole.
Proximal coronary artery visualization was obtained without
contrast medium injection, and at least 30 consecutive
images were obtained at 3-mm intervals beginning 1 cm
below the carina and progressing caudally to include the
proximal coronary arteries. Total radiation exposure using
this technique was ,1 rad per patient.
The lesion score was calculated by multiplying the lesion
area by a density factor derived from the maximal
Hounsfield unit (Hu) within this area, as previously de-
scribed (1). The density factor was assigned in the following
manner: 1 for lesions whose maximal density was 130 to 199
Hu, 2 for lesions 200 to 299 Hu, 3 for lesions 300 to 399 Hu
and 4 for lesions .400 Hu. A total calcium score (CS) was
determined by adding individual lesion scores from each of
four anatomic sites (left main, left anterior descending,
circumflex and right coronary arteries). Neither patients nor
treating physicians were aware of the results of the coronary
scan.
Determination of end points. Follow-up was done by
hospital record review by an investigator blinded to EBT
data. Standard coronary disease risk factors (e.g., hypercho-
lesterolemia, hypertension, diabetes, smoking and family
history of premature coronary disease) were obtained from
direct measurements from the hospital chart. Patients were
determined to have hypercholesterolemia if they had a total
fasting cholesterol of .240 mg/dl or increased low-density
cholesterol (.160 mg/dl) or decreased high-density choles-
terol (,35 mg/dl) or were on cholesterol-lowering medica-
tion. Subjects were identified with hypertension if they had
repeated elevated measures of blood pressure (.140/90) or
were on antihypertensive therapy. Participants currently
using insulin or oral hypoglycemic agents were classified as
diabetic, as well as patients having fasting blood sugar $126
mg/dl or random blood sugar $200 mg/dl. Cigarette
smoking was defined as current use of .10 cigarettes per
day. Follow-up time was determined as the period between
patient enrollment (scan date) and last contact (inpatient or
outpatient) in the medical record. All end points were
determined by consensus of three reviewers blinded to the
EBT results and previous hospitalizations. Patients with
acute MI had two of three criteria: chest pain lasting
.30 min, rise and fall of creatine kinase with MB fraction
.4% and new pathologic Q waves of .0.04 s duration (16).
Coronary revascularization procedures, ischemic stroke (by
standard neurological and computed tomographic criteria)
and subsequent hospitalization for angina were included.
Only cardiac death, either sudden death associated with a
chest pain syndrome or assessed by autopsy, was included.
Noncardiac deaths (n 5 5) were excluded from analysis.
Only one event was counted for each patient, in the following
order of importance: coronary death, MI, revascularization
procedure, stroke and hospitalization for angina.
Statistical analysis. Means were expressed 6 SD. To
examine the relation of incident MI, cardiac death, revas-
cularization and hospitalization for angina and stroke, the
Student t test was used. Multivariate logistic regression
analyses were performed using models with the occurrence
of hard events and any cardiovascular events as the depen-
dent variable. Independent variables were selected for inclu-
sion in the models from those variables that were signifi-
cantly correlated with outcome on univariate regression
analysis. The analyses were performed using traditional risk
factors (derived from the initial admission to the ED),
including age, race, gender, elevated total cholesterol, hy-
pertension, current cigarette smoking, diabetes mellitus and
family history of premature heart disease. Adjusted odds
ratios (OR) and 95% confidence intervals (CI) were calcu-
lated from the multivariate logistic regression variable esti-
mates.
RESULTS
Of the 221 patients originally scanned, 13 were excluded
from follow-up due to acute cardiac event upon initial
Abbreviations and Acronyms
CAC 5 coronary artery calcium
CI 5 confidence interval
CS 5 calcium score
EBT 5 electron beam tomography
ECG 5 electrocardiogram
ED 5 emergency department
Hu 5 Hounsfield unit
MI 5 myocardial infarction
OR 5 odds ratio
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presentation. Follow-up was obtained in 192 patients of the
remaining 208 (92%), mean age of 53 6 9 years. Average
follow-up was 50 6 10 months (1 to 84 months). Eighty-
eight (46%) were women (mean age: 55 years 6 10 years),
104 were men (mean age: 52 years 6 12 years).
Of the 192 patients, 69 (36%) were Caucasian, 48 (25%)
were African American, 26 (14%) were Asian American and
49 (26%) were Hispanic. There were no significant differ-
ences in the prevalence of CAC (score .0) in different racial
groups, except Hispanics (white 72%, African American
52%, Asian American 69%, Hispanic 47%). Prevalence of
coronary calcium was significantly lower among Hispanics
as compared with Caucasians (47% vs. 73%, p 5 0.004).
Hypertension, hypercholesterolemia, premature family his-
tory and tobacco use were all significantly more prevalent
among those who suffered cardiac events as compared with
those patients in the no event group (p , 0.05 for all
measures).
During the follow-up period, 58 subjects (30%) had
cardiac events. There were 30 (15.6%) hard events con-
firmed by medical records (11 cardiac deaths, 19 nonfatal
MIs) and 28 (14.6%) other cardiovascular events (9 bypass
surgeries, 4 angioplasties, 11 hospitalizations for angina and
4 ischemic strokes). Racial differences with regard to coro-
nary events were evaluated. Clinical characteristics are
presented in Table 1. Hispanics had a significantly lower
coronary event rate when compared with Caucasians. These
differences persisted after controlling for age, standard
cardiac risk factors and gender using logistic regression.
However, these differences were not significant once the
presence of coronary calcium was added to the model. No
other racial differences were noted in this study.
For the entire study group, scores ranged from 0 to 4,607.
The 25th, 50th and 75th percentile scores were 0, 4 and
332, respectively. For hard events (MI and cardiac death),
there were no events in the first quartile, 1 in the second
quartile, 10 in the third quartile and 19 in the fourth
quartile. For total cardiovascular events (n 5 58), there were
2 in the first quartile, 1 in the second quartile, 27 in the
third quartile and 27 in the fourth quartile. The mean CS
for those who did not suffer a cardiac event was 240 6 698
as compared with 595 6 636 for those who suffered a hard
event (p 5 0.009 as compared with those in the no event
group) and 446 6 550 for those with any cardiovascular
events (p 5 0.03 as compared with those in the no event
group).
The sensitivity, specificity, positive and negative predic-
tive values and overall accuracy are listed in Table 2 for
different scoring thresholds and age- and gender-adjusted
thresholds. The annualized event rate (all cardiovascular
events) was 0.6% for the 76 subjects with a CAC score of 0
compared with 13.9% per year for the 38 subjects with a
CAC score .400 (p , 0.001). There was a graded relation
between the CAC score category and the incidence of
cardiovascular event (Fig. 1). Twenty-two of 38 patients
with scores .400 had cardiac events during the follow-up
(positive predictive value 58%). Cox proportional-hazards
regression showed CAC to be associated with a greater risk
for having a new cardiovascular event independent of age,
gender, race and other risk factors. Those with any CAC
had an increased risk of new cardiovascular events (OR:
27.8, 95% CI: 1.88, 815, p 5 0.02).
Adjustment for age and gender further risk stratified
patients, those with CAC in the third and fourth quartiles
had an RR of 13.1 (95% CI: 5.6, 36, p , 0.001) for new
cardiovascular events as compared with those in the lower
two quartiles (Fig. 2). Twenty-eight of 30 hard cardiac
events occurred in patients with above average age- and
gender-adjusted scores (51% to 99%). A majority of patients
who suffered a hard event (MI or death) had a CAC score
in the upper range of normal (88% .50th percentile, 64%
.75th percentile). The positive predictive value over a short
follow-up period was 49% for both groups. Fifty-one of 58
(88%) total cardiovascular events occurred in the top two
quartiles of age- and gender-adjusted scores. Multivariate
logistic regression analysis demonstrated CAC score and
age- and gender-matched calcium percentiles to be the
strongest predictors of future events. Age, male gender
and hypertension were the only other independent pre-
dictors of future cardiovascular events in the model.





Number of patients (n) 134 58 192
Age (mean 6 SD) 52 6 10 56 6 10 53 6 10
Men (%) 53 56 54
Race (%)
Caucasian 32 45 36
African American 23 29 25
Asian American 15 10 14
Hispanic 30 14* 26
Hypertension (%) 55 74* 61
Diabetes (%) 22 27 24
Dyslipidemia (%) 32 48* 37
Premature family history (%) 21 36* 26
Smoking (%) current 32 46* 36
*p , 0.05 prevalence in no events versus events.
Table 2. Electron Beam Tomography for Hard and All
Coronary Events at Various Calcium Score Thresholds




.0 1.00 0.47 0.26 1.00 0.55
.4 (median) 0.97 0.51 0.27 0.99 0.58
.332 0.63 0.81 0.39 0.92 0.79
All Events
.0 0.97 0.55 0.48 0.97 0.68
.4 (median) 0.93 0.59 0.55 0.95 0.69
.332 0.47 0.83 0.55 0.78 0.72
$50% 0.88 0.60 0.49 0.92 0.69
$75% 0.64 0.72 0.49 0.82 0.69
NPV 5 negative predictive value; PPV 5 positive predictive value.
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These results are summarized in Table 3, along with
corresponding OR and CI.
DISCUSSION
Coronary artery calcification is highly predictive of future
cardiac events. Every prognostic study of EBT demonstrates
that CAC burdens predict future cardiac events (5–10).
This study, representing a long follow-up of symptomatic
persons presenting to the ED with chest pain, is consistent
with other studies, demonstrating a graded relation between
the extent of CAC and the incidence of future cardiovas-
cular events. This study demonstrates that CS percentiles,
based on patient age and gender, are better predictors than
absolute CS and categorical risk factors. Detrano et al. (6)
examined the prognostic value of EBT CS for predicting
cardiovascular events in 491 patients undergoing cardiac
angiography and found a 10-fold event rate increase in
patients with CS over the 75th percentile as compared with
those below the 25th percentile (OR: 10.8, 95% CI: 1.4 to
85.6). Logistic regression including gender, age, CS and
angiographically diseased vessels showed that only EBT CS
predicted events. This study, also in symptomatic patients,
demonstrates a similar increase in predictive power. Similarly,
studies of asymptomatic persons all demonstrate highly signif-
icant event prediction using CAC scores (7–10).
Calcium detection and events. All cases of cardiac death
and MI occurred in patients with CAC. One case of
percutaneous revascularization and one ischemic stroke
occurred in the absence of CAC. Both the treating physi-
cian and patient were blinded to the result of the EBT led
to the relatively low rate of revascularization and significant
rate of fatal and nonfatal MI. This blinding increases the
likelihood that this study was free of treatment bias (where
patients with positive scores have increased utilization of
pharmacologic therapy that can prevent future events),
which most likely leads to an underestimation of the power
of CAC to predict future events (7–10). Persons with
coronary calcium have been reported to be more likely to
Figure 1. Annualized rates for future cardiovascular events by Cox proportional-hazards regression. Patients with scores .400 had an event rate of 58%
over the entire study, with an annualized event rate of 13.9%. This was significantly greater than the 0.6% annual event rate of those with scores of zero
(p , 0.001).
Figure 2. Relative risks for total cardiovascular events, using age- and gender-adjusted quartiles by multivariate logistic regression. The relative risk of those
patients with high age- and gender-adjusted scores (.75th percentile) was 12-fold higher than those with no or little coronary calcium (0 to 25th
percentile). Confidence intervals (95%) are displayed for each quartile.
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undertake preventive health measures, including beginning
cholesterol- or blood pressure-lowering medications, start-
ing aspirin, beginning an exercise program, following a
low-fat diet or quitting smoking (17).
The lower incidence of coronary events in Hispanics as
compared with Caucasians in this study is significant (p 5
0.01). The difference in event rates was at least partially
explained by the lower prevalence of coronary calcium
among Hispanics in this study (47%). This lower athero-
sclerotic burden among Hispanics might explain the lower
overall mortality rates from coronary disease (as compared
with Caucasians) reported in large studies (18).
Calcium scanning in the ED. The use of EBT in an ED
setting has been previously reported (12,14). These studies
demonstrate that patients presenting to the ED with
angina-like chest pain and normal or indeterminate ECG
findings may be effectively triaged based upon results of the
EBT scan. These studies demonstrate sensitivities of 98% to
100% for identifying patients with acute MI. The high
sensitivity and negative predictive value may allow early
discharge of those patients with nondiagnostic ECG and
negative EBT scans (scores 5 0). Four month follow-up
demonstrated no cardiac events in the study by Laudon et al.
(12), concluding that EBT is a rapid and efficient screening
tool for such patients in the ED setting. The reluctance to
utilize the test more widely for patients with chest pain
stems from the limited follow-up in these studies (15). The
results of this observational clinical study extend follow-up
to seven years, supporting the use of EBT in a symptomatic
cohort, with prompt discharge of those patients with neg-
ative scans. The risk of immediate MI is negligible, and the
annual event rate is well below ,1%.
The use of EBT as a risk assessment tool should improve
the physician’s ability to stratify individuals at high risk of
events, to whom aggressive treatment of risk factors for
coronary artery disease can be more appropriately directed, and
help direct the admission or discharge of emergency room
patients. Almost half of all symptomatic patients with age- and
gender-adjusted scores .50th percentile had a cardiovascular
event in the next 50 months (positive predictive value 49%).
Study limitations. The number of patients enrolled was
small. While the scanner was open 50% of the time, many
patients who fit the entry criteria were not enrolled from the
ED. While there was no obvious enrollment bias, it is
important to note that this study of symptomatic patients
was not inclusive of all types of patients presenting to the
ED. Patients with prior MI or revascularization or ECG or
enzyme changes consistent with an acute MI were felt to
need admission regardless of coronary calcium and were,
thus, not included. The racial diversity was fair; however,
the small number of patients precludes any assessment of
racial differences.
The event rate of this study group was very high, even
during the relatively short follow-up period. Thirty percent
of patients had a cardiovascular event during the subsequent
50 months. This was a symptomatic cohort, with a high
incidence of cardiovascular risk factors, especially hyperten-
sion and diabetes. Neither patients nor treating physicians
were aware of the results of the coronary scan. While this
allowed an unbiased approach to the patient with regard to
the treatment for chest pain, the utilization of cholesterol-
reducing medications, aspirin and other antiatherosclerotic
medications was subsequently low. The follow-up (mean 50
months, maximum up to eight years) was incomplete, and
many patients, as this study was performed at a county
facility, were lost to follow-up after only several months.
Our results imply that EBT may be a sufficiently powerful
tool to be used in the ED to decide the need for admission
in patients presenting with chest pain and nondiagnostic
ECGs. To fully assess the potential of this tool, long-term
prognostic power must be demonstrated in larger studies.
Conclusions. This study demonstrated that EBT is an effi-
cient and safe test to use in patients presenting to the ED with
acute chest pain, allowing rapid discharge with a negative scan.
Furthermore, the absence of calcium implies a very low (0.6%
annual) incidence of coronary events, whereas the presence of
coronary calcium is an independent predictor of future cardiac
events. These data support previous reports showing CAC,
especially in age- and gender-matched cohorts, to be a very
strong predictor of future cardiovascular events.
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